PUBLISHER: KBV Research | PRODUCT CODE: 1462020
PUBLISHER: KBV Research | PRODUCT CODE: 1462020
North America Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030
The North America Arthritic Therapeutic Market would witness market growth of 4.5% CAGR during the forecast period (2023-2030).
The US market dominated the North America Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $31,321.7 Million by 2030. The Canada market is experiencing a CAGR of 6.8% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.9% during (2023 - 2030).
Adopting arthritic therapeutics hinges on the availability of safe and efficacious treatments that effectively alleviate symptoms, preserve joint function, and enhance overall quality of life. Clinical trials and real-world evidence demonstrating the benefits of various pharmacological and non-pharmacological interventions are crucial in informing treatment decisions and shaping clinical practice guidelines.
The adoption of this is influenced by the availability and accessibility of healthcare infrastructure, like rheumatology clinics, primary care providers, physical therapy facilities, and diagnostic services. Adequate healthcare resources, including trained personnel, medical equipment, and pharmaceutical supplies, are essential for delivering comprehensive arthritis care and implementing evidence-based treatment protocols.
According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Arthritis is one of the most common chronic conditions among older adults in Canada. Hence, the factors mentioned above will drive the regional market growth.
Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- AbbVie, Inc.
- Pfizer, Inc.
- Amgen, Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Viatris, Inc.
- Bausch Health Companies, Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
North America Arthritic Therapeutic Market Report Segmentation
By Application
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Osteoarthritis
- Ankylosing Spondylitis
- Others
By Product Type
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Disease Modified Anti-rheumatoid Drugs (DMARDs)
- Biologics
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America Arthritic Therapeutic Market, by Application
- 1.4.2North America Arthritic Therapeutic Market, by Product Type
- 1.4.3North America Arthritic Therapeutic Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market
Chapter 5.North America Arthritic Therapeutic Market, by Application
- 5.1North America Rheumatoid Arthritis Market, by Country
- 5.2North America Psoriatic Arthritis Market, by Country
- 5.3North America Osteoarthritis Market, by Country
- 5.4North America Ankylosing Spondylitis Market, by Country
- 5.5North America Others Market, by Country
Chapter 6.North America Arthritic Therapeutic Market, by Product Type
- 6.1North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
- 6.2North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
- 6.3North America Biologics Market, by Country
- 6.4North America Others Market, by Country
Chapter 7.North America Arthritic Therapeutic Market, by Country
- 7.1US Arthritic Therapeutic Market
- 7.1.1US Arthritic Therapeutic Market, by Application
- 7.1.2US Arthritic Therapeutic Market, by Product Type
- 7.2Canada Arthritic Therapeutic Market
- 7.2.1Canada Arthritic Therapeutic Market, by Application
- 7.2.2Canada Arthritic Therapeutic Market, by Product Type
- 7.3Mexico Arthritic Therapeutic Market
- 7.3.1Mexico Arthritic Therapeutic Market, by Application
- 7.3.2Mexico Arthritic Therapeutic Market, by Product Type
- 7.4Rest of North America Arthritic Therapeutic Market
- 7.4.1Rest of North America Arthritic Therapeutic Market, by Application
- 7.4.2Rest of North America Arthritic Therapeutic Market, by Product Type
Chapter 8.Company Profiles
- 8.1AbbVie, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
- 8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
- 8.2.5.1Acquisition and Mergers:
- 8.2.6SWOT Analysis
- 8.3Amgen, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
- 8.3.5.1Acquisition and Mergers:
- 8.3.6SWOT Analysis
- 8.4Novartis AG
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
- 8.4.5.1Trials and Approvals:
- 8.4.6SWOT Analysis
- 8.5F. Hoffmann-La Roche Ltd.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
- 8.6Viatris, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
- 8.6.5.1Trials and Approvals:
- 8.6.6SWOT Analysis
- 8.7Bausch Health Companies, Inc
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
- 8.8Sanofi S.A.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5Recent strategies and developments:
- 8.8.5.1Partnerships, Collaborations, and Agreements:
- 8.8.6SWOT Analysis
- 8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
- 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
- 8.10.Bristol-Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis
LIST OF TABLES
- TABLE 1North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
- TABLE 2North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
- TABLE 3North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
- TABLE 4North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
- TABLE 5North America Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
- TABLE 6North America Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
- TABLE 7North America Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
- TABLE 8North America Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
- TABLE 9North America Osteoarthritis Market, by Country, 2019 - 2022, USD Million
- TABLE 10North America Osteoarthritis Market, by Country, 2023 - 2030, USD Million
- TABLE 11North America Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
- TABLE 12North America Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
- TABLE 13North America Others Market, by Country, 2019 - 2022, USD Million
- TABLE 14North America Others Market, by Country, 2023 - 2030, USD Million
- TABLE 15North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
- TABLE 16North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
- TABLE 17North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
- TABLE 18North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
- TABLE 19North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
- TABLE 20North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
- TABLE 21North America Biologics Market, by Country, 2019 - 2022, USD Million
- TABLE 22North America Biologics Market, by Country, 2023 - 2030, USD Million
- TABLE 23North America Others Market, by Country, 2019 - 2022, USD Million
- TABLE 24North America Others Market, by Country, 2023 - 2030, USD Million
- TABLE 25North America Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
- TABLE 26North America Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
- TABLE 27US Arthritic Therapeutic Market, 2019 - 2022, USD Million
- TABLE 28US Arthritic Therapeutic Market, 2023 - 2030, USD Million
- TABLE 29US Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
- TABLE 30US Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
- TABLE 31US Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
- TABLE 32US Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
- TABLE 33Canada Arthritic Therapeutic Market, 2019 - 2022, USD Million
- TABLE 34Canada Arthritic Therapeutic Market, 2023 - 2030, USD Million
- TABLE 35Canada Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
- TABLE 36Canada Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
- TABLE 37Canada Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
- TABLE 38Canada Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
- TABLE 39Mexico Arthritic Therapeutic Market, 2019 - 2022, USD Million
- TABLE 40Mexico Arthritic Therapeutic Market, 2023 - 2030, USD Million
- TABLE 41Mexico Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
- TABLE 42Mexico Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
- TABLE 43Mexico Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
- TABLE 44Mexico Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
- TABLE 45Rest of North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
- TABLE 46Rest of North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
- TABLE 47Rest of North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
- TABLE 48Rest of North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
- TABLE 49Rest of North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
- TABLE 50Rest of North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
- TABLE 51Key information - AbbVie, Inc.
- TABLE 52Key Information - Pfizer, Inc.
- TABLE 53Key Information - Amgen, Inc.
- TABLE 54Key Information - Novartis AG
- TABLE 55Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 56Key Information - Viatris, Inc.
- TABLE 57key information - Bausch Health Companies, Inc.
- TABLE 58Key Information - Sanofi S.A.
- TABLE 59Key Information - Merck & Co., Inc.
- TABLE 60Key Information - Bristol-Myers Squibb Company
